Enter the last name, specialty or keyword for your search below.
Roland Griffiths, left, and Matthew Johnson frequently visit the research pharmacy in the Johns Hopkins Behavioral Pharmacology Research Unit. There, pharmacists and pharmacy technicians prepare psilocybin capsules that are administered in psilocybin research studies.
Tapping into Psilocybin’s Potential
In re-evaluating hallucinogenic drugs, psychopharmacologists Matthew Johnson and Roland Griffiths have discovered psilocybin’s potential to treat various disorders, including obsessive-compulsive disorder and inflammatory disease.
Read More
Probing Deep Brain Stimulation for Alzheimer’s Disease
Neuropsychologist Gwenn Smith and psychiatrist Constantine Lyketsos have been collaborating on a multicenter phase II study of deep brain stimulation in patients ages 45 to 85 with Alzheimer’s disease. The results show some benefit to the older patients.
A Boon for Children’s Mental Health Services
Pediatrician and psychiatrist Larry Wissow has been named the inaugural recipient of a professorship honoring the late Johns Hopkins pediatric psychiatrist James Connaughton. And that means expanded services for patients and their families.
Self-Harming Behavior in Children with Autism: Can Electroconvulsive Therapy Help?
Whether they resort to head banging, scratching or biting, children with autism who demonstrate self-injurious behaviors autism may find electroconvulsive therapy helpful, according to psychiatrist Irving Reti.
A roundup of brain research and thinking underway at Johns Hopkins offers a glimpse of recent insights.
Announcing two new books by Susan Lehmann and Kay Redfield Jamison — on bipolar disorder in older patients and Robert Lowell’s genius and mania, respectively.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
